申请人:Sheridan Joseph M.
公开号:US20140018540A1
公开(公告)日:2014-01-16
The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.